About Indivumed inc.
Indivumed Inc. - Your Resource for Precision Oncology
Indivumed Inc. is a global oncology company that is committed to shaping the future of individualized cancer therapy. The company was founded in 2002 by Dr. Hartmut Juhl, a pathologist and cancer researcher who recognized the need for high-quality biospecimens to support cancer research.
Today, Indivumed is a leading provider of biospecimens and related services for cancer research and drug development. The company has established a unique biobank of human tissue samples that are collected under strict quality control standards and annotated with clinical data.
Indivumed's mission is to accelerate the development of personalized cancer therapies by providing researchers with access to high-quality biospecimens and cutting-edge technologies. The company's approach is based on the principle that every patient's tumor is unique, and therefore requires an individualized treatment approach.
To achieve this goal, Indivumed has developed a comprehensive suite of services that includes:
1) Biobanking: Indivumed collects fresh-frozen tissue samples from consenting patients undergoing surgery or biopsy procedures at partner hospitals around the world.
2) Pathology: Indivumed employs expert pathologists who analyze tissue samples using state-of-the-art techniques such as immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), and next-generation sequencing (NGS).
3) Molecular Profiling: Indivumed offers molecular profiling services using its proprietary OncoTrack platform, which combines genomic, transcriptomic, proteomic, and metabolomic data to provide a comprehensive view of each patient's tumor.
4) Data Analysis: Indivumed provides bioinformatics analysis services to help researchers interpret complex molecular data sets generated from their studies.
5) Drug Development Support: Indivumed works closely with pharmaceutical companies to support drug discovery efforts by providing preclinical testing services using its biobank resources.
Indivumed's commitment to quality extends beyond its biospecimen collection process. The company has implemented rigorous quality control measures throughout its operations to ensure that all data generated from its studies are accurate and reliable.
In addition, Indivumed has established partnerships with leading academic institutions around the world to advance cancer research through collaborative projects. These partnerships have resulted in numerous publications in top-tier scientific journals such as Nature Medicine, Cancer Research, and Clinical Cancer Research.
Overall, Indivumed Inc.'s innovative approach towards precision oncology makes it an invaluable resource for researchers seeking new insights into cancer biology or developing novel therapies for patients suffering from this devastating disease. With its extensive biobank resources coupled with cutting-edge technologies like OncoTrack platform combined with expert pathology analysis team make it one-of-a-kind service provider globally!
indivumed.com
